Funding for this research was provided by:
Received: 6 May 2020
Accepted: 31 July 2020
First Online: 11 September 2020
Ethics approval and consent to participate
: The study was approved by the Danish ethical committee (H-16043365) and was conducted in accordance with the Declaration of Helsinki. All patients signed a written informed consent before any study procedures.
: Not applicable.
: Sara Christiansen has received speaker fees from Bristol Myers Squibb (BMS) and General Electric (GE). Felix Müller is an employee of Siemens Healthineers. Lene Terslev has received speaker fees from AbbVie, MSD, Novartis, Roche, Pfizer, General Electric (GE), Bristol Myers Squibb (BMS) and Janssen. Mikkel Østergaard has received research support and/or consultancy/speaker fees from AbbVie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Centocor, GSK, Hospira, Janssen, Merck, Mundipharma, Novartis, Novo, Orion, Pfizer, Regeneron, Schering-Plough, Roche, Takeda, UCB and Wyeth.Ole Slot, Jakob Møller, Henrik Børgesen and Kasper Gosvig have no potential conflicts of interests.